Table 3. Summary of the effects of drug treatment on cell cycle progression in MOLT4 cells.

Condition	G0/G1	S-Phase	G2/M	SubG1
DMSO	40.0 ± 3.2%	27.1 ± 2.5%	25.0 ± 3.1%	7.9 ± 1.4% (0%)
100 μM TMZ	41.0 ± 4.1%	19.8 ± 1.5%	21.4 ± 2.4%	17.8 ± 2.5% (9.9%)
10 μg/mL 3-Eth-5-NIdR	40.8 ± 3.9%	23.1 ± 3.2%	21.5 ± 2.1%	14.6 ± 1.9% (6.7%)
Combination	34.8 ± 2.5%	18.9 ± 1.9%	15.4 ± 1.5%	30.9 ± 2.9% (23.0%)

Values represent an average of three (3) independent determinations performed on different days. Values in parentheses represent the difference in percent sub-G1 DNA measured with various treatments compared to treatment with DMSO (vehicle control).